{"title":"涎腺及口腔黏膜按摩对缓解精神分裂症患者口干症的疗效观察","authors":"Yuki Iwashima , Yutaka Watanabe , Kimiya Ozaki , Eri Arai , Kazuhito Miura , Ayako Yokoyama , Miyako Kondo , Seitaro Nakazawa , Matsuhiko Oka , Kazutaka Okada , Takae Matsushita , Yutaka Yamazaki","doi":"10.1016/j.ajoms.2024.11.011","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To investigate the effectiveness of salivary-gland and oral-mucosa massage in alleviating xerostomia, which is an adverse effect of antipsychotics, in patients with schizophrenia and to investigate factors associated with its efficacy and clarify its indications.</div></div><div><h3>Methods</h3><div>In this randomized controlled trial, 47 patients with chronic schizophrenia were randomly divided into the intervention and control groups. The intervention group underwent salivary-gland and oral-mucosa massage and was followed up from baseline to week 8. The control group was assessed at baseline and after 8 weeks.</div></div><div><h3>Results</h3><div>Overall, 30 patients completed the study (15 in the intervention group and 15 in the control group). In the intervention group, the salivary flow rate stimulated by the chewing gum test significantly increased after 8 weeks. Furthermore, the use of first-generation antipsychotic (FGA) equivalents was significantly higher in patients whose salivary flow rate was unchanged after salivary gland oral-mucosal massage than in patients who showed improvement. Compared with the patients who used SGA alone, those who used second-generation antipsychotics (SGAs) and FGAs had less recognition of the tendency for salivary secretion to increase, and most of them used levomepromazine, an FGA with high muscarinic receptor affinity.</div></div><div><h3>Conclusions</h3><div>Salivary-gland and oral-mucosa massage may promote salivation in patients with chronic schizophrenia. FGA intake inhibited the effects of the massage, and levomepromazine may have influenced this inhibition. Understanding the interactions between levomepromazine and salivary-gland and oral-mucosa massage can improve treatment strategies and patient care in chronic schizophrenia.</div></div>","PeriodicalId":45034,"journal":{"name":"Journal of Oral and Maxillofacial Surgery Medicine and Pathology","volume":"37 3","pages":"Pages 500-511"},"PeriodicalIF":0.4000,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effectiveness of salivary-gland and oral-mucosa massage in alleviating xerostomia in patients with schizophrenia\",\"authors\":\"Yuki Iwashima , Yutaka Watanabe , Kimiya Ozaki , Eri Arai , Kazuhito Miura , Ayako Yokoyama , Miyako Kondo , Seitaro Nakazawa , Matsuhiko Oka , Kazutaka Okada , Takae Matsushita , Yutaka Yamazaki\",\"doi\":\"10.1016/j.ajoms.2024.11.011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><div>To investigate the effectiveness of salivary-gland and oral-mucosa massage in alleviating xerostomia, which is an adverse effect of antipsychotics, in patients with schizophrenia and to investigate factors associated with its efficacy and clarify its indications.</div></div><div><h3>Methods</h3><div>In this randomized controlled trial, 47 patients with chronic schizophrenia were randomly divided into the intervention and control groups. The intervention group underwent salivary-gland and oral-mucosa massage and was followed up from baseline to week 8. The control group was assessed at baseline and after 8 weeks.</div></div><div><h3>Results</h3><div>Overall, 30 patients completed the study (15 in the intervention group and 15 in the control group). In the intervention group, the salivary flow rate stimulated by the chewing gum test significantly increased after 8 weeks. Furthermore, the use of first-generation antipsychotic (FGA) equivalents was significantly higher in patients whose salivary flow rate was unchanged after salivary gland oral-mucosal massage than in patients who showed improvement. Compared with the patients who used SGA alone, those who used second-generation antipsychotics (SGAs) and FGAs had less recognition of the tendency for salivary secretion to increase, and most of them used levomepromazine, an FGA with high muscarinic receptor affinity.</div></div><div><h3>Conclusions</h3><div>Salivary-gland and oral-mucosa massage may promote salivation in patients with chronic schizophrenia. FGA intake inhibited the effects of the massage, and levomepromazine may have influenced this inhibition. Understanding the interactions between levomepromazine and salivary-gland and oral-mucosa massage can improve treatment strategies and patient care in chronic schizophrenia.</div></div>\",\"PeriodicalId\":45034,\"journal\":{\"name\":\"Journal of Oral and Maxillofacial Surgery Medicine and Pathology\",\"volume\":\"37 3\",\"pages\":\"Pages 500-511\"},\"PeriodicalIF\":0.4000,\"publicationDate\":\"2024-11-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Oral and Maxillofacial Surgery Medicine and Pathology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2212555824002436\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"DENTISTRY, ORAL SURGERY & MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Oral and Maxillofacial Surgery Medicine and Pathology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212555824002436","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
Effectiveness of salivary-gland and oral-mucosa massage in alleviating xerostomia in patients with schizophrenia
Objective
To investigate the effectiveness of salivary-gland and oral-mucosa massage in alleviating xerostomia, which is an adverse effect of antipsychotics, in patients with schizophrenia and to investigate factors associated with its efficacy and clarify its indications.
Methods
In this randomized controlled trial, 47 patients with chronic schizophrenia were randomly divided into the intervention and control groups. The intervention group underwent salivary-gland and oral-mucosa massage and was followed up from baseline to week 8. The control group was assessed at baseline and after 8 weeks.
Results
Overall, 30 patients completed the study (15 in the intervention group and 15 in the control group). In the intervention group, the salivary flow rate stimulated by the chewing gum test significantly increased after 8 weeks. Furthermore, the use of first-generation antipsychotic (FGA) equivalents was significantly higher in patients whose salivary flow rate was unchanged after salivary gland oral-mucosal massage than in patients who showed improvement. Compared with the patients who used SGA alone, those who used second-generation antipsychotics (SGAs) and FGAs had less recognition of the tendency for salivary secretion to increase, and most of them used levomepromazine, an FGA with high muscarinic receptor affinity.
Conclusions
Salivary-gland and oral-mucosa massage may promote salivation in patients with chronic schizophrenia. FGA intake inhibited the effects of the massage, and levomepromazine may have influenced this inhibition. Understanding the interactions between levomepromazine and salivary-gland and oral-mucosa massage can improve treatment strategies and patient care in chronic schizophrenia.